³Ô¹Ï±¬ÁÏ Ranked 2nd Fastest-Growing Enterprise Software Company by Fortune Magazine
Fortune recognition among additional accolades from Deloitte, PM360,
and Pharmaceutical Manufacturing for continued growth and innovation
PLEASANTON, CA ¡ª Jan. 8, 2019 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE:VEEV) today announced that it was ranked the second fastest-growing enterprise software company on Fortune magazine¡¯s list and one of the fastest-growing software companies in Deloitte¡¯s??survey.
PM360 magazine also recognized ³Ô¹Ï±¬ÁÏ¡¯s continued product innovation and leadership, naming ³Ô¹Ï±¬ÁÏ Nitro one of the . In addition, Pharmaceutical Manufacturing magazine named ³Ô¹Ï±¬ÁÏ Vault Training as a winner for advancing role-based training in quality manufacturing.
¡°Thanks to the ³Ô¹Ï±¬ÁÏ team for their focused execution and commitment to product excellence,¡± said Peter Gassner, founder and CEO of ³Ô¹Ï±¬ÁÏ. ¡°We¡¯re proud of the strong partnership we have forged with the life sciences industry and the continued opportunities to support our customers¡¯ success.¡±
Fortune Ranks ³Ô¹Ï±¬ÁÏ as Fast-Growing Company for Second Consecutive Year
Fortune ranked ³Ô¹Ï±¬ÁÏ the second and number 18 overall on its 100 Fastest-Growing Companies list. The annual list ranks the top performers in revenues, profits, and stock returns over the past three years.
Deloitte Names ³Ô¹Ï±¬ÁÏ a 2018 Technology Fast 500™ Winner
Deloitte recognized ³Ô¹Ï±¬ÁÏ as one of the fastest-growing public and private technology companies in North America. This is the fifth consecutive year that ³Ô¹Ï±¬ÁÏ has been named to the Deloitte Technology Fast 500™.
¡°These companies are innovators who have converted their disruptive ideas into products, services, and experiences that can captivate new customers and drive remarkable growth,¡± said Sandra Shirai, vice chairman, Deloitte LLP, and U.S. technology, media, and telecommunications leader.
PM360 Selects ³Ô¹Ï±¬ÁÏ Nitro as a 2018 Most Innovative Product
In its annual Innovations Issue, PM360 recognized ³Ô¹Ï±¬ÁÏ Nitro as one of 2018¡¯s Most Innovative ³Ô¹Ï±¬ÁÏ. ³Ô¹Ï±¬ÁÏ Nitro eliminates the time and effort of custom data warehouse development and maintenance with an industry-specific solution for life sciences that is analytics and AI-ready.
¡°Our selections represent the companies, offerings, and strategies that demonstrate what we believe is unique in their ability to impact the industry,¡± said Anna Stashower, CEO and publisher of PM360. ¡°We hope others in the industry are able to work with these innovators or use these innovations to better serve patients, physicians, and other healthcare stakeholders.¡±
Pharmaceutical Manufacturing Recognizes ³Ô¹Ï±¬ÁÏ for Product Innovation
The Pharma Innovation Award highlights technologies and systems from companies that have distinguished themselves as industry leaders. Pharmaceutical Manufacturing acknowledged ³Ô¹Ï±¬ÁÏ Vault Training for delivering a centralized view of training across an organization.
¡°³Ô¹Ï±¬ÁÏ¡¯s training system has the potential to reduce validation times from months to days,¡± said Karen Langhauser, chief content director at Pharmaceutical Manufacturing. ¡°Pharmaceutical equipment suppliers invest a large amount of time into their products, so we feel this innovation should be recognized.¡±
Additional Information
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ has more than 675 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.
###
Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com